Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    March 09-10, 2026

    14th Global Summit on Artificial Intelligence and Neural Networks

    Singapore City, Singapore
    April 29-30, 2026

    MECHATRONICS CONFERENCE 2026

    Dubai, UAE
    December 09-10, 2026

    25th International Conference on Big Data & Data Analytics

    Amsterdam, Netherlands

    Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in